Atlas Trials

Effects of SGLT2 Inhibitor on Hemodynamic Parameters in Resistant Hypertensive Subjects

Clinical trial NCT03089333 · COMPLETED

Trial details

NCT number
NCT03089333
Sponsor
University of Campinas, Brazil
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
HypertensionDiabetes Mellitus, Type 2Blood PressureObesityCardiac HypertrophyMicroalbuminuriaVascular Stiffness
Start date
2016-07-01
Primary completion
2017-10-01
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.